Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study - Concepedia

Concepedia

Publication | Open Access

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study

DOI Full Paper Access

75

Citations

47

References

2020

Year

Alessandro M. Vannucchi, Benedetta Sordi, A Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, Alessandro Bartoloni, Alessandro Atanasio, Filippo Miselli, Chiara Paoli,

References

	Year	Citations

Page 1